Clinical trial to investigate causes of diabetes, obesity in individuals with spinal cord injury ...
A $3 million NIH-funded study led by Marzieh Salehi, MD, MS, at UT Health San Antonio investigates the antidiabetic and anti-obesity effects of semaglutide in people with spinal cord injury, aiming to impact treatment guidelines and understand underlying diabetes mechanisms in this population.
Reference News
Clinical trial to investigate causes of diabetes, obesity in individuals with spinal cord injury ...
A $3 million NIH-funded study led by Marzieh Salehi, MD, MS, at UT Health San Antonio investigates the antidiabetic and anti-obesity effects of semaglutide in people with spinal cord injury, aiming to impact treatment guidelines and understand underlying diabetes mechanisms in this population.